BC2 - Basel Computational Biology Conference

      Date
      Sep 12, 2017 - Sep 15, 2017
      Location
      Congress Center Basel: MCH Messe Schweiz Basel Switzerland
      The 13th [BC]2 - the Basel Computational Biology Conference - is the key computational biology event in Switzerland in 2017 uniting scientists working in a broad range of disciplines, including bioinformatics, computational biology, neuroscience, medicine, and systems biology. [BC]2 will take place 12th-15th September 2017 in Basel, Switzerland.  The main conference 13-15 September will take place at the Congress Center in Basel. The Workshops and Tutorials on Tuesday 12th of September will take place at the Kollegienhaus of the University of Basel. Participation at [BC]2 will be the prime opportunity to learn about cutting-edge research in computational biology and bioinformatics and to network with other members of our community. [BC]2 will feature highlight presentations of latest scientific results, workshops, tutorials, poster sessions, and keynotes lectures by international experts. [BC]2 Basel Computational Biology conference is the scientific symposium of the SIB Swiss Institute of Bioinformatics, organized in collaboration with the Biozentrum University of Basel.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.